Data / Form D filings / ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.: Form D filings
ClearPoint Neuro, Inc., a biotechnology company in Solana Beach, CA, filed 16 Form D notices with the SEC between 2009 and 2026. The latest, on February 5, 2026, reports $17.9 million sold of a $17.9 million offering to 46 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 120 S. SIERRA AVENUE SUITE 100, Solana Beach, CA, 92075
- Phone
- (949) 900-6833
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1285550
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | New notice | $17,892,698 | $17,892,698 | 46 | Nov 20, 2025 | sec.gov | |
| May 29, 2019 | New notice | $7,522,000 | $7,522,000 | 17 | May 17, 2019 | sec.gov | |
| Jun 6, 2017 | New notice | $13,250,000 | $13,250,000 | 60 | May 26, 2017 | sec.gov | |
| Sep 13, 2016 | New notice | $6,005,000 | $6,005,000 | 24 | Sep 2, 2016 | sec.gov | |
| Dec 21, 2015 | New notice | $5,294,000 | $5,294,000 | 57 | Dec 18, 2015 | sec.gov | |
| Dec 23, 2014 | New notice | $10,175,550 | $10,175,550 | 74 | Dec 9, 2014 | sec.gov | |
| Apr 1, 2014 | Amendment | $3,725,000 | $3,725,000 | 10 | Mar 25, 2014 | sec.gov | |
| Mar 12, 2014 | New notice | $7,500,000 | $0 | $7,500,000 | 0 | Yet to occur | sec.gov |
| Feb 7, 2013 | New notice | $11,042,021 | $11,042,021 | 47 | Jan 25, 2013 | sec.gov | |
| Jul 16, 2012 | New notice | $6,000,000 | $6,000,000 | 65 | Jul 2, 2012 | sec.gov | |
| Oct 21, 2011 | New notice | $6,000,000 | $150,000 | $5,850,000 | 1 | Oct 14, 2011 | sec.gov |
| Sep 14, 2011 | Amendment | $1,400,000 | $1,310,000 | $90,000 | 6 | Jun 30, 2011 | sec.gov |
| Jul 15, 2011 | New notice | $1,150,000 | $500,000 | $650,000 | 2 | Jun 30, 2011 | sec.gov |
| Oct 22, 2010 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
| Mar 4, 2010 | New notice | $4,600,000 | $0 | $4,600,000 | 0 | Yet to occur | sec.gov |
| Nov 6, 2009 | New notice | $4,250,000 | $2,000,000 | $2,250,000 | 1 | Oct 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph M. Burnett | Executive Officer, Director | |
| R. John Fletcher | Director | |
| Lynnette C. Fallon | Director | |
| Pascal E.R. Girin | Director | |
| B. Kristine Johnson | Director | |
| Matthew B. Klein | Director | |
| Linda M. Liau | Director | |
| Timothy T. Richards | Director | |
| Danilo D'Alessandro | Executive Officer | |
| Jeremy L. Stigall | Executive Officer | |
| Mazin Sabra | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Feb 2, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ClearPoint Neuro, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.